BML-280（Cat No.:I012129）is a potent and selective peptide inhibitor primarily used in research involving protein kinase signaling. It inhibits the activity of certain protein kinases, particularly those involved in cellular processes like cell growth, apoptosis, and inflammation. This makes BML-280 a valuable tool in studying cancer, autoimmune diseases, and other inflammatory disorders. By blocking specific kinase pathways, BML-280 provides insights into the regulation of cell signaling and offers potential therapeutic applications. Its high specificity allows for targeted modulation, reducing off-target effects in experimental settings.